Clinical Trials Browser

Giant Cell Tumor of Bone

NCT03449108 2025-11-21

LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas

BreastEndocrineGynecologicHead & NeckSarcoma

Bone Neoplasms, Ovarian Neoplasms, Sarcoma, Osteosarcoma, Giant Cell Tumor of Bone, Histiocytoma, Malignant Fibrous, Triple Negative Breast Neoplasms, Thyroid Carcinoma, Anaplastic

NCT07227961 2025-11-13

PROMIS and Mobility Evaluation in Sarcoma Patients

Recruiting

800 enrolled

Sarcoma

Alzheimer Disease, Sarcoma, Giant Cell Tumor of Bone

NCT03295981 2025-10-15

Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of Bone

Phase 3 Recruiting

120 enrolled

Giant Cell Tumor of Bone

NCT06647901 2024-10-18

Efficacy of ICG-based NIR Imaging in Intralesional Curettage of Giant Cell Tumors of Bone in Limbs: a Prospective, Single-center, Single-arm, Open Study

Phase 1/2 Recruiting

45 enrolled

Giant Cell Tumor of Bone

NCT05595603 2023-03-15

Zoledronic Acid-loaded Bone Cement as a Local Adjuvant Therapy for Giant Cell Bone Tumor After Intralesional Curettage

Phase 2 Recruiting

153 enrolled

Giant Cell Tumor of Bone

NCT04952818 2021-07-07

The Value of Preoperative Diagnosis and Prognostic Prediction Based on Radiomics of Giant Cell Tumor of Spine

Completed

100 enrolled

CNS

Recurrence, Spinal Cord Neoplasms, Giant Cell Tumor of Bone

NCT04002817 2021-05-04

Giant Cell Tumor of the Bone in Young Patients

Completed

18 enrolled

Giant Cell Tumor of Bone

NCT00464620 2018-11-23

Trial of Dasatinib in Advanced Sarcomas

Phase 2 Completed

366 enrolled 16 charts

GastrointestinalSarcoma

Chondrosarcoma, Chordoma, Hemangiopericytoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Giant Cell Tumor of Bone, Sarcoma, Alveolar Soft Part, Neurofibrosarcoma, Gastrointestinal Stromal Tumors, Solitary Fibrous Tumors

NCT03358212 2017-11-30

Safety and Efficacy of Post-operative Denosumab Strategy for Giant Cell Tumor of Bone Treatment in China

Unknown

100 enrolled

Giant Cell Tumor of Bone

NCT03259152 2017-08-24

D-Gct

Phase 3 Unknown

30 enrolled

Giant Cell Tumor of Bone

Clinical Trials

ICG-GCTB

LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas

PROMIS and Mobility Evaluation in Sarcoma Patients

Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of Bone

Efficacy of ICG-based NIR Imaging in Intralesional Curettage of Giant Cell Tumors of Bone in Limbs: a Prospective, Single-center, Single-arm, Open Study

Zoledronic Acid-loaded Bone Cement as a Local Adjuvant Therapy for Giant Cell Bone Tumor After Intralesional Curettage

The Value of Preoperative Diagnosis and Prognostic Prediction Based on Radiomics of Giant Cell Tumor of Spine

Giant Cell Tumor of the Bone in Young Patients

Trial of Dasatinib in Advanced Sarcomas

Safety and Efficacy of Post-operative Denosumab Strategy for Giant Cell Tumor of Bone Treatment in China

D-Gct